Cencora/$COR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cencora
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
- Ticker
- $COR
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 49,000
- Headquarters
- Conshohocken, United States
- Website
- www.cencora.com
Cencora Metrics
BasicAdvanced
$60bn
23.34
$13.46
-
$2.35
0.76%
Price and volume
Market cap
$60bn
52-week high
$377.54
52-week low
$244.82
Average daily volume
1.5m
Dividend rate
$2.35
Financial strength
Current ratio
0.935
Quick ratio
0.477
Long term debt to equity
424.544
Total debt to equity
446.516
Dividend payout ratio (TTM)
17.83%
Interest coverage (TTM)
8.78%
Profitability
EBITDA (TTM)
5,546.476
Gross margin (TTM)
3.96%
Net profit margin (TTM)
0.79%
Operating margin (TTM)
1.35%
Effective tax rate (TTM)
26.82%
Revenue per employee (TTM)
$6,790,000
Management effectiveness
Return on assets (TTM)
3.56%
Return on equity (TTM)
96.87%
Valuation
Price to earnings (TTM)
23.339
Price to revenue (TTM)
0.183
Price to book
19.65
Price to tangible book (TTM)
-3.12
Price to free cash flow (TTM)
15.008
Free cash flow yield (TTM)
6.66%
Free cash flow per share (TTM)
20.933
Dividend yield (TTM)
0.75%
Forward dividend yield
0.76%
Growth
Revenue change (TTM)
5.09%
Earnings per share change (TTM)
39.11%
3-year revenue growth (CAGR)
9.36%
10-year revenue growth (CAGR)
8.68%
3-year earnings per share growth (CAGR)
18.02%
10-year earnings per share growth (CAGR)
6.18%
3-year dividend per share growth (CAGR)
7.06%
10-year dividend per share growth (CAGR)
6.02%
What the Analysts think about Cencora
Analyst ratings (Buy, Hold, Sell) for Cencora stock.
Cencora Financial Performance
Revenues and expenses
Cencora Earnings Performance
Company profitability
Cencora News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.